TITLE

RainDance has PCR platform validated in consortium paper

AUTHOR(S)
PEDERSEN, AMANDA
PUB. DATE
September 2013
SOURCE
Medical Device Daily;9/18/2013, Vol. 17 Issue 180, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses research on the use of the digital polymerase chain reaction (PCR) technology developed by medical device firm RainDance Technologies for detecting tumor DNA mutation in blood samples. The study was conducted in collaboration with Université Paris Sorbonne Cité and University of Strasbourg researchers, published in the August 12, 2013 online issue of "Clinical Chemistry" journal. The value of this PCR technology in enabling cancer research is also emphasized.
ACCESSION #
90375144

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics